Skip to main content

Contact Sjoerd H van der Burg

From: HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

Contact corresponding author